David Hovland

Consejero General en ELEDON PHARMACEUTICALS, INC. .

Health Technology

Consumer Services

Perfil

David Hovland is currently the Chief Regulatory Officer at Eledon Pharmaceuticals, Inc. Prior to this, he was the Senior Vice President-Global Regulatory Affairs at Urovant Sciences Ltd.
from 2018 to 2021.
He was also the Vice President-Global Regulatory Affairs at Allergan Ltd.
(Ireland) from 2015 to 2018.
Before that, he was the Director-Global Regulatory Affairs at Amgen, Inc. from 2006 to 2010.
He started his career as a Study Director at Allergan Ltd.
(Ireland) from 1999 to 2002.
Dr. Hovland holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.

Cargos activos de David Hovland

Empresas	Cargo	Inicio
ELEDON PHARMACEUTICALS, INC.	Consejero General	19/04/2021

Todos los cargos activos de David Hovland

Antiguos cargos conocidos de David Hovland.

Empresas	Cargo	Fin
UROVANT SCIENCES LTD.	Consejero General	01/04/2021
ALLERGAN PLC	Consejero General	01/01/2018
AMGEN INC.	Consejero General	01/01/2010
ALLERGAN PLC	Corporate Officer/Principal	01/01/2002

Ver el detalle de la experiencia de David Hovland.

Formación de David Hovland.

University of California, Los Angeles	Doctorate Degree
University of California, Berkeley	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Hovland.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
AMGEN INC.	Health Technology
ELEDON PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	2
Urovant Sciences Ltd. Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.	Health Technology
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland.	Health Technology